Imatinib might constitute a treatment option for lung involvement in COVID-19.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/56305

Title:	Imatinib might constitute a treatment option for lung involvement in COVID-19.
Authors:	Bernal-Bello, David Jaenes-Barrios, Beatriz Morales-Ortega, Alejandro Ruiz-Giardin, José Manuel García-Bermúdez, Virginia Frutos-Pérez, Begoña Farfán-Sedano, Ana Isabel de Ancos-Aracil, Cristina Bermejo, Fernando García-Gil, Mario Zapatero-Gaviria, Antonio San Martín-López, Juan Víctor View more
Mesh:	Betacoronavirus COVID-19 Coronavirus Infections Cytokines Humans Imatinib Mesylate Interleukin-6 Macrophage Activation Syndrome Pandemics Pneumonia, Viral SARS-CoV-2 View more
Issue Date:	3-May-2020
Citation:	Autoimmun Rev.2020;(19)7:102565
PMID:	32376403
URI:	https://hdl.handle.net/20.500.12530/56305
Rights:	openAccess
Appears in Collections:	Centros de Atención Primaria > Artículos

Files in This Item:

File	Size	Format
PMC7252139.pdf	236.14 kB	Adobe PDF	View/Open